TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification February 5, 1999